SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-007096
Filing Date
2024-03-06
Accepted
2024-03-06 18:00:15
Documents
2
Period of Report
2024-03-04

Document Format Files

Seq Description Document Type Size
1 form4-03062024_060307.html 4  
1 form4-03062024_060307.xml 4 4045
2 ex24-03062024_060307.htm EX-24 5325
  Complete submission text file 0001415889-24-007096.txt   11023
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVE SOUTH SAN FRANCISCO CA 94080
Business Address
Curley Joanne (Reporting) CIK: 0001857670 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 24727376